ABBV options flow: unusual options activity in AbbVie Inc.

Updated 28 September 2026, 09:54 ET

Over the last week the tape recorded 63 unusual options prints in AbbVie Inc. (ABBV), $3.7M of tracked premium, leaning bullish. Bullish premium was $1.8M against $1.2M bearish; $2.5M went into calls and $1.2M into puts, a put call ratio of 0.49. The largest print was $475K of ABBV 19 Mar 2027 $240 puts on 21 September 2026, executed at bid. The last session with prints, 28 September 2026, added 1 print and $44K of premium. ABBV closed at $264.34 on 25 September 2026, down 0.3%.

This week's unusual flow

Unusual prints63
Tracked premium$3.7M
Net premium+$588K
Bullish premium$1.8M
Bearish premium$1.2M
Call premium$2.5M
Put premium$1.2M
P/C ratio0.49
Sweeps38%
Size over OI14
Whale prints0
High conviction4

Prints from 21 September 2026 to 28 September 2026, 6 sessions. Delayed tier: every print is shown twenty minutes after it executed, and the page is rebuilt after each session.

Net premium is bullish minus bearish premium. The put call ratio is put premium divided by call premium, weighted by money rather than by contract count. Sweeps is the share of prints executed across several exchanges at once. Read the guide: Reading the Pulse.

Largest prints of the week

DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
21 Sep 2026ABBV 19 Mar 2027 $240 putsTrade450738$475KAt bidBullishNotable
22 Sep 2026ABBV 17 Sep 2027 $330 callsTrade25090$279KAt bidBearishNotable
21 Sep 2026ABBV 16 Oct 2026 $267.50 callsSweep4620$263KAt askBullishHigh conviction
22 Sep 2026ABBV 16 Oct 2026 $260 callsSweep2102,664$184KAt bidBearishNotable
24 Sep 2026ABBV 6 Nov 2026 $265 callsTrade1000$105KAt askBullishNotable
24 Sep 2026ABBV 2 Oct 2026 $267.50 putsSweep16418$99KAt bidBullishHigh conviction
24 Sep 2026ABBV 16 Oct 2026 $220 callsSweep22334$97KAt bidNeutral
24 Sep 2026ABBV 25 Sep 2026 $260 callsTrade200366$96KAt bidBearish
22 Sep 2026ABBV 16 Oct 2026 $260 callsSweep1002,664$88KAt bidBearishNotable
23 Sep 2026ABBV 20 Nov 2026 $260 callsTrade401,947$68KAt askBullish
25 Sep 2026ABBV 17 Sep 2027 $160 putsTrade30061$68KAt bidBullishNotable
22 Sep 2026ABBV 21 Jan 2028 $300 callsSweep25856$58KAt askNeutral

Size above open interest means the trade opened a position larger than everything that existed in the contract the night before. Above ask and below bid are the most aggressive executions. Read the guide: Size versus open interest.

Where the money is aimed

ExpiryPrintsPremiumCalls shareNet premium
16 Oct 202614$967K90%+$203K
19 Mar 20273$533K5%+$417K
17 Sep 20272$346K81%-$211K
21 Jan 20288$326K80%-$91K
20 Nov 20267$287K72%+$120K
19 Jan 20297$266K100%+$11K

The most premium, $967K, is aimed at the 16 Oct 2026 expiry.

A print in a contract expiring this week is a view about the next few days, often about a known event; a print months out is a different kind of statement. Read the guide: 0DTE options flow.

The last session, 28 September 2026

Prints1
Premium$44K
Net premium+$0
P/C ratio0.00
Sweeps0%
DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
28 Sep 2026ABBV 15 Jan 2027 $260 callsTrade233,073$44KAt bidNeutral

Every print in ABBV with its full detail, the live tape, one tap filters and saved screeners: open ABBV in Options Sentiment Screener.

Price

Last close$264.34
Day-0.29%
1 week+0.14%
1 month+0.55%
3 months+4.34%
1 year+20.16%
52 week high$269.39
52 week low$190.75
Volume2,541,719
Market cap$468.5B

The live quote and the price chart sit beside the ticker's flow in the app: open ABBV in Options Sentiment Screener.

Analysts

The most recent analyst targets on file, from 19 firms, have a median of $285, 7.8% above the last close. The last 90 days brought 2 upgrades.

Calls bought at a strike above the average target are a bet that the analysts are too cautious; puts far below the price in a name they like are protection or a strong disagreement. Read the guide: Reading one ticker's flow.

About AbbVie Inc.

Exchange
NYSE
Sector
Health Care
Industry
Pharmaceutical Products
Headquarters
North Chicago, Illinois
Website
abbvie.com

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism.

In the same sector

Flow pages for other Health Care names in the S&P 500:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonMRK Merck & Co. Inc.UNH UnitedHealth Group Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.ABT Abbott Laboratories

Learn

The live tape for ABBV with every print's execution detail, one tap filters for calls, puts, sweeps and 0DTE, saved screeners and, for Realtime subscribers, push alerts and no delay. The same screen is in the iOS and Android apps.

Open ABBV in Options Sentiment Screener